LEONARD JOHN M
CIK 1563584
Transactions on file
12
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-08-24 | 2026-08-21 | NTLA Intellia Therapeutics, Inc. | President and CEO | Sale | 2,785 | $36.2K | -13.4% | open → |
| 2026-08-24 | 2026-08-20 | NTLA Intellia Therapeutics, Inc. | President and CEO | Sale | 19,890 | $250.6K | -10.6% | open → |
| 2026-04-27 | 2026-04-23 | IQV IQVIA HOLDINGS INC. | Director | Grant | 1,571 | $0.00 | — | open → |
| 2025-01-03 | 2025-01-01 | NTLA Intellia Therapeutics, Inc. | OfficerDirector President and CEO | Exer. | 7,850 | — | — | open → |
| 2025-01-07 | 2025-01-03 | NTLA Intellia Therapeutics, Inc. | OfficerDirector President and CEO | Sale | 26,807 | $326.5K | -7.6% | open → |
| 2025-03-04 | 2025-03-01 | NTLA Intellia Therapeutics, Inc. | OfficerDirector President and CEO | Grant | 136,000 | $0.00 | — | open → |
| 2025-04-25 | 2025-04-24 | IQV IQVIA HOLDINGS INC. | Director | Grant | 1,592 | $0.00 | — | open → |
| 2025-12-12 | 2025-12-12 | NTLA Intellia Therapeutics, Inc. | President and CEO | Exer. | 8,557 | $58.4K | +64.9% | open → |
| 2025-12-12 | 2025-12-11 | NTLA Intellia Therapeutics, Inc. | President and CEO | Sale | 5,355 | $51.4K | +17.4% | open → |
| 2025-12-12 | 2025-12-11 | NTLA Intellia Therapeutics, Inc. | President and CEO | Sale | 32,832 | $310.9K | +18.9% | open → |
| 2025-12-12 | 2025-12-11 | NTLA Intellia Therapeutics, Inc. | President and CEO | Sale | 49,959 | $474.1K | +18.7% | open → |
| 2025-12-12 | 2025-12-11 | NTLA Intellia Therapeutics, Inc. | President and CEO | Exer. | 49,959 | $341.2K | +64.9% | open → |
